Since the initial characterization of the rodent model in 1974, many laboratories have investigated the pathophysiology of the response to intratracheal bleomycin challenge. In rodents, bleomycin administration results in a route, dose, and strain dependent pulmonary inflammatory response. Given intratracheally, this response is characterized by increases in leukocyte accumulation, fibroblast proliferation, and collagen content. We hypothesized that an unremitting profibrotic inflammatory response is a cause of dysregulated fibrogenesis. Further, we believe that characterization of the cell types and soluble mediators present in the lesion will lend significant insight into the processes modulating pulmonary fibrosis. Recent studies have id...
Fibrosis and structural remodeling of the lung tissue can significantly impair lung function, often ...
Bleomycin (BLM), an anti-tumor drug, has been observed to cause interstitial pneumonia followed by s...
Abstract Background Reactive oxygen species and tissue remodeling regulators, such as metalloprotein...
Since the initial characterization of the rodent model in 1974, many laboratories have investigated ...
Abstract: Previously, macrophage inflammatory protein-1a (MIP-1a), a member of the C-C chemo-kine fa...
Pulmonary fibrosis is the end point of a chronic inflammatory process characterized by leukocyte rec...
Previously, macrophage inflammatory protein‐1α (MIP‐1α), a member of the C‐C chemokine family, has b...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
A progressive fibrosing phenotype is critical in several lung diseases. It is irreversible and assoc...
Pulmonary fibrosis is a common response to a variety of lung injuries, characterized by fibroblast/m...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
RATIONALE: Different sensitivities to profibrotic compounds such as bleomycin are observed among mou...
Although interstitial lung disease (ILD) is a life-threatening pathological condition that causes re...
Background: Pulmonary hypertension (PH) is a common complication of idiopathic pulmonary fibrosis (I...
BACKGROUND: Reactive oxygen species and tissue remodeling regulators, such as metalloproteinases (MM...
Fibrosis and structural remodeling of the lung tissue can significantly impair lung function, often ...
Bleomycin (BLM), an anti-tumor drug, has been observed to cause interstitial pneumonia followed by s...
Abstract Background Reactive oxygen species and tissue remodeling regulators, such as metalloprotein...
Since the initial characterization of the rodent model in 1974, many laboratories have investigated ...
Abstract: Previously, macrophage inflammatory protein-1a (MIP-1a), a member of the C-C chemo-kine fa...
Pulmonary fibrosis is the end point of a chronic inflammatory process characterized by leukocyte rec...
Previously, macrophage inflammatory protein‐1α (MIP‐1α), a member of the C‐C chemokine family, has b...
IPF is a chronic, progressive pulmonary disease, leading to respiratory failure. In search of mechan...
A progressive fibrosing phenotype is critical in several lung diseases. It is irreversible and assoc...
Pulmonary fibrosis is a common response to a variety of lung injuries, characterized by fibroblast/m...
Bleomycin (BLM) induction of lung fibrosis in mice is an established model to study the mechanism of...
RATIONALE: Different sensitivities to profibrotic compounds such as bleomycin are observed among mou...
Although interstitial lung disease (ILD) is a life-threatening pathological condition that causes re...
Background: Pulmonary hypertension (PH) is a common complication of idiopathic pulmonary fibrosis (I...
BACKGROUND: Reactive oxygen species and tissue remodeling regulators, such as metalloproteinases (MM...
Fibrosis and structural remodeling of the lung tissue can significantly impair lung function, often ...
Bleomycin (BLM), an anti-tumor drug, has been observed to cause interstitial pneumonia followed by s...
Abstract Background Reactive oxygen species and tissue remodeling regulators, such as metalloprotein...